“You can’t manage what you don’t measure.” The world community–led by the IMACS and PRINTO groups–has developed robust core criteria to measure disease activity and damage for Juvenile Dermatomyositis studies. These measures are tremendously useful in clinical practice, and not just for research. More problematic has been determining clinically meaningful change. The current definitions of chan...